Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Lifestory Health Inc. manages 1 pending office action in the Chemistry & Materials technology area. Prosecution is handled by 1 distinct examiner, Dwan A Gerido, within 1 distinct art unit. Dwan A Gerido is the busiest examiner, with 1 pending office action. The portfolio's current activity is limited to this single examiner and art unit. This indicates a concentrated prosecution effort for the company's pending chemistry and materials matters.
The presence of 1 distinct examiner, Dwan A Gerido, and 1 distinct art unit simplifies the tracking of the company's active matters. Because the 1 pending office action is the only one currently in progress, the examiner's specific tendencies will be the primary driver of the prosecution timeline. This centralized arrangement within the Chemistry & Materials sector allows for a more direct and focused legal strategy. Practitioners should focus on the specific procedural requirements of the 1 distinct art unit to ensure a successful outcome for this pending application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17699095 | Devices and Methods for Female Health Monitoring | GERIDO, DWAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17699095 | Devices and Methods for Female Health Monitoring | GERIDO, DWAN A | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17699095 | Devices and Methods for Female Health Monitoring | GERIDO, DWAN A | 1797 | §101§102 | Non-Final OA | — | Pending | Mar 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLifestory Health Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Dwan A Gerido has the most, with 1 of Lifestory Health Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
